Skip to main content
Journal ArticleOPEN ACCESS

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

  • Denton C
  • Hachulla É
  • et al.
Arthritis & Rheumatology (2017) 69(12) 2370-2379
DOI: 10.1002/art.40242
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The primary objective of the study is to determine the activity of selexipag on Raynaud attack frequency in subjects with Raynaud's Phenomenon (RP) secondary to Systemic Sclerosis (SSc).

Cite

CITATION STYLE

APA

Denton, C. P., Hachulla, É., Riemekasten, G., Schwarting, A., Frenoux, J., … Herrick, A. L. (2017). Efficacy and Safety of Selexipag in Adults With Raynaud’s Phenomenon Secondary to Systemic Sclerosis. Arthritis & Rheumatology, 69(12), 2370–2379. https://doi.org/10.1002/art.40242

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free